Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: SAVA

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Peering Into Cassava Sciences Inc’s Recent Short Interest

By Benzinga Insights
Today, 5:58 AM
Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has risen 22.31% since last its last report. The company recently reported that it has 10.25 million shares sold short, which is 27.47% of all regular shares that are available for trading.

SAVA

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
Today, 5:58 AM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

CVS

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Are The Shorts Feeling About Cassava Sciences Inc?

By Benzinga Insights
Today, 5:58 AM
Cassava Sciences Inc's (NASDAQ:SAVA) short interest has increased 22% since the last report. The company recently reported that it has 10 million shares sold short, which is 27.47% of its float, the amount of regular shares that are available to investors for trading.

SAVA

Read More
2 minute read
  • Markets
  • Options

Cassava Sciences Whale Trades Spotted

By Benzinga Insights
Today, 5:58 AM
A whale with a lot of money to spend has taken a noticeably bearish stance on Cassava Sciences. Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 12 strange trades.

SAVA

Read More
1 minute read
  • News

Cassava Sciences Highlights Launch Of Clinical Website To Support Phase 3 Studies Of Oral Simufilam In Alzheimer’s Disease

By Benzinga Newsdesk
Today, 5:58 AM
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants.   Rethink-ALZ.com connects patients with nearest participating clinical

SAVA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Media
  • Movers
  • Trading Ideas

Cassava Sciences Shares Spike To Session High; TipRanks Tweets Article ‘Cassava Stock to Hit $215? This Analyst Thinks It’s Possible’

By Benzinga Newsdesk
Today, 5:58 AM
https://twitter.com/TipRanks/status/1473734224343670800

SAVA

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

(SAVA) – Analyzing Cassava Sciences Inc’s Short Interest

By Benzinga Insights
Today, 5:58 AM
Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 26.17% since last its last report. The company recently reported that it has 8.38 million shares sold short, which is 22.46% of all regular shares that are available for trading.

SAVA

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today

By Benzinga Insights
Today, 5:58 AM
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 41.64% on an annualized basis.

SAVA

Read More
1 minute read
  • Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Wednesday, Dec. 22, 2021: TSLA, SEAC, SAVA, DCRN, METX

By Benzinga Newsdesk
Today, 5:58 AM
Today's 5 Stock Ideas: Tesla (TSLA) - A Form 4 filing from Elon Musk Tuesday evening showed the sale of Tesla stock by Musk. Investors are breathing a collective sigh of release as the disclosure of the sale

DCRN

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

55 Biggest Movers From Yesterday

By Lisa Levin
Today, 5:58 AM
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday.

ACAD

Posts navigation

Previous 1 … 9 10 11 … 25 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service